Please use this identifier to cite or link to this item: https://gnanaganga.inflibnet.ac.in:8443/jspui/handle/123456789/7952
Full metadata record
DC FieldValueLanguage
dc.contributor.authorD. Kamalaveni-
dc.contributor.authorS. Kalaiselvi-
dc.date.accessioned2024-02-27T06:23:14Z-
dc.date.available2024-02-27T06:23:14Z-
dc.date.issued2010-
dc.identifier.urihttp://gnanaganga.inflibnet.ac.in:8080/jspui/handle/123456789/7952-
dc.description.abstractToday, the Indian Pharmaceutical industry is in the front rank of India's science - based industries with wide ranging capabilities in the complex field of drug manufacturing and technology. As a highly organized sector, the Indian pharma industry is estimated to be worth $4.5 billion, growing at about 8 to 9 percent annually. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured.-
dc.publisherIndian Journal of Finance-
dc.titleDeterminants of Dividend in Indian Pharmaceutical Industry - A study of Select Companies-
dc.volVol 4-
dc.issuedNo 3-
Appears in Collections:Articles to be qced

Files in This Item:
File SizeFormat 
Determinants of Dividend In Indian Pharmaceutical Industry.pdf
  Restricted Access
1.64 MBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.